CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krieger, N.
Right arrow Articles by Weuve, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krieger, N.
Right arrow Articles by Weuve, J.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 405-411, May 2003
© 2003 American Association for Cancer Research

Breast Cancer, Birth Cohorts, and Epstein-Barr Virus

Methodological Issues in Exploring the "Hygiene Hypothesis" in Relation to Breast Cancer, Hodgkin’s Disease, and Stomach Cancer1

Nancy Krieger2,,3, Emily Ficklin Strong4, Christine Makosky4 and Jennifer Weuve5

Departments of Health and Social Behavior [N. K., E. F. S., C. M.], and Epidemiology [J. W.], Harvard School of Public Health, Boston, Massachusetts 02115

To address methodological issues in exploring a variant of the "hygiene hypothesis" that posits delayed infection by Epstein-Barr virus contributes to rising rates of breast cancer and Hodgkin’s disease, we examined birth cohort trends in the incidence of both cancers plus stomach cancer, building on previously reported year-of-diagnosis cross-sectional associations of age-standardized rates. Using published data from the United States Connecticut state cancer registry (1935–1998) for women for each cancer site, we obtained age-specific incidence rates by birth cohort (1870–1874 to 1970–1974), along with age-standardized incidence rates for selected calendar years (1935–1939, 1940–1944, ..., 1990–1994, 1995–1998). Clear secular trends in incidence rates, in the opposite direction, were evident for: (a) breast cancer and for Hodgkin’s disease in young adults (increasing), and (b) stomach cancer (decreasing). Correlations between the incidence of breast cancer among women ages 50–54 and Hodgkin’s disease among young adults (ages 20–24) were stronger for birth cohort (Pearson correlation, 0.85) than for cross-sectional analyses (Pearson correlation, 0.68). Stronger associations between the incidence of breast cancer and non-Hodgkin’s disease were evident for birth cohort compared with cross-sectional analyses, findings consonant with (but not "proof" of) the hygiene hypothesis. One methodological implication is that tests of the hygiene hypothesis must take into account birth cohort effects and age at incidence of the outcomes under study; age-standardized cross-sectional analyses may be misleading.




This article has been cited by other articles:


Home page
Journal of the American Dental AssociationHome page
A. H. FRIEDLANDER, E. C. SUNG, and J. S. CHILD
Radiation-induced heart disease after Hodgkin's disease and breast cancer treatment: Dental implications
J Am Dent Assoc, December 1, 2003; 134(12): 1615 - 1620.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2003 by the American Association for Cancer Research.